Catheter Precision (FRA:4RM) Total Current Assets: €1.08 Mil (As of Mar. 2026)


FRA:4RM Catheter Precision Inc FRA:4RM
23 GF Score
Price €100.89
GF Value €218.38
! 7 Warning Signs
View Full Analysis

What is Catheter Precision Total Current Assets?

Catheter Precision FRA:4RM 23 Total Current Assets is €1.08 Mil as of Mar. 2026. GuruFocus rates FRA:4RM with a GF Score™ of 23/100 and a GF Value™ of €218.38. The stock has 7 warning signs investors should review.

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. Catheter Precision's total current assets for the quarter that ended in Mar. 2026 was €1.08 Mil.

Catheter Precision  (FRA:4RM) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

Catheter Precision's Liquidation Value for the quarter that ended in Mar. 2026 is

Liquidation value
= Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=0.381-22.428+0.75 * 0.226+0.5 * 0.054
=-21.85

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Catheter Precision Total Current Assets Related Terms

Catheter Precision Total Current Assets Historical Data

* Premium members only.

The historical data trend for Catheter Precision's Total Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Catheter Precision Total Current Assets Chart

Catheter Precision Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Current Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.12 15.89 3.82 3.14 0.33

Catheter Precision Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Current Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.79 1.77 2.10 0.33 1.08
FRA:4RM
23GF Score
Catheter Precision Inc FRA:4RM
Total Current Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Catheter Precision Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

Catheter Precision's Total Current Assets for the fiscal year that ended in Dec. 2025 is calculated as

Total Current Assets=Cash, Cash Equivalents, Marketable Securities+Total Receivables+Total Inventories+Other Current Assets
=0.075+0.132+0.073+0.053
=0.33

Catheter Precision's Total Current Assets for the quarter that ended in Mar. 2026 is calculated as

Total Current Assets=Cash, Cash Equivalents, Marketable Securities+Total Receivables+Total Inventories+Other Current Assets
=0.381+0.226+0.054+0.419
=1.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Frequently Asked Questions Learn more about Total Current Assets →
What does a Total Current Assets of €1.08 Mil mean?
Catheter Precision (FRA:4RM) has a Total Current Assets of €1.08 Mil as of Mar. 2026. The total amount of assets with liquidity less than one year as recorded on a company's balance sheet. View historical data for Catheter Precision and its competitors.
Is Catheter Precision's Total Current Assets too high?
Catheter Precision's current Total Current Assets is €1.08 Mil. Overall, Catheter Precision has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Catheter Precision's Total Current Assets compare to ALURD and BJDX?
Catheter Precision's Total Current Assets of €1.08 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Current Assets for a Medical Devices & Instruments company?
A good Total Current Assets depends on the Medical Devices & Instruments industry context. However, Total Current Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Current Assets mean?
A high Total Current Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets with liquidity less than one year as recorded on a company's balance sheet. View historical data for Catheter Precision and its competitors. Catheter Precision's current Total Current Assets is €1.08 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Catheter Precision stock overvalued right now?
Catheter Precision (FRA:4RM) has a current Total Current Assets of €1.08 Mil. The stock's GF Value™ is €218.38, compared to a current price of €100.89 — trading 53.8% below its estimated fair value. The current Total Current Assets is €1.08 Mil. Catheter Precision's overall GF Score™ is 23/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Current Assets calculated?
Total Current Assets is calculated from a company's financial statements. For Catheter Precision (FRA:4RM), the current Total Current Assets is €1.08 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Catheter Precision (FRA:4RM) Overvalued in 2026?

Based on GuruFocus' analysis, Catheter Precision stock appears to be undervalued. The current stock price of €100.89 is trading 53.8% below its estimated GF Value™ of €218.38.

Key valuation signals for FRA:4RM:

  • Total Current Assets: €1.08 Mil
  • GF Value™: €218.38 vs. price of €100.89 (53.8% below fair value)
  • GF Score™: 23/100 with 7 warning signs

No single metric tells the full story. See the FRA:4RM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Catheter Precision Business Description

Other Exchanges VTAK:USA
Address 1670 Highway 160 West, Suite 205, Fort Mill, SC, USA, 29708
Catheter Precision Inc is engaged in the design, manufacture, and sale of medical technologies focused in the field of cardiac electrophysiology, or EP. The company's two primary products include the VIVO System and LockeT. The VIVO System, which is an acronym for View into Ventricular Onset System(VIVO or VIVO System), is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its newest product, LockeT, is a suture retention device indicated for wound healing by distributing suture tension over a larger area in the patient in conjunction with a figure of eight suture closure.
23GF Score

Get the complete analysis for FRA:4RM

Total Current Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€100.89
Price
€218.38
GF Value